To further validate the hypothesis that both NKX2-1 expression and hypomethylation of R1 region of ABI3 gene are required for ABI3 expression, thyroid carcinoma and non-thyroid carcinoma cells were treated with demethylating-associated agent 5-aza-dC. The gene discussed is NKX2-1; the disease is thyroid gland carcinoma.